Ida Hude-Dragičević

5PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyCardiology (incl. cardiovascular diseases)HaematologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2025
Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases.

Igor Aurer, Ozren Jakšić, Sandra Bašić-Kinda

|Mar 28, 2024
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).

Ida Hude Dragičević, Sandra Bašić-Kinda, Helena Markotić

|Nov 20, 2020
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience.

Sandra Bašić-Kinda, Ivo Radman, Dino Dujmović

|Jun 19, 2018
Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone

Ida Hude, Josip Batinić, Sandra Bašić Kinda

|Apr 26, 2017
Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.

Ida Hude, Stephanie Sasse, Paul J Bröckelmann

Pageof 1

Frequent Collaborators

2 joint publications

Sandra Bašić-Kinda

2 joint publications

Lea Galunić-Bilić

2 joint publications

Igor Aurer

1 joint publications

Josip Batinić